Indicators

Markets:

News

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 4 Next >

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

July 06, 2023

Alzheimer’s Disease, RSV, Migraines and more…

June 22, 2023

Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research

June 21, 2023

Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action

June 07, 2023

Medicare details plan to cover Alzheimer's treatments

June 01, 2023

Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

May 12, 2023

FDA commissioner praises Eli Lilly Alzheimer's treatment results

May 03, 2023

Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial

May 03, 2023

Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says

April 25, 2023

March 2023 Miscellany

March 27, 2023

Getting Back to You on Anavex, Cassava, metformin and more

January 17, 2023

Relevant Updates – December 2022

December 27, 2022

Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months

November 14, 2022

A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia

November 13, 2022

Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation

November 07, 2022

Odd & Ends – October 2022

October 27, 2022

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

September 28, 2022

Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock

September 28, 2022

Following Up on Your Suggestions – September 2022

September 26, 2022

Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon

August 10, 2022

EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate

August 04, 2022

Alzheimer’s Drug Development — July Responses to Questions & Requests

July 19, 2022

AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector

July 08, 2022

Alzheimer’s Disease June 2022 – Possible Signs of Progress

June 13, 2022

Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm

May 23, 2022

Alzheimer’s Disease May 2022 – Is There Anything New?

May 10, 2022

Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug

May 10, 2022

New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall

April 19, 2022

EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial

April 13, 2022

Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes

April 08, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.